Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Dvorchik

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 15, 2000
Effects of cisplatin dose intensity on response and survival for patients with unresectable and untransplantable hepatocellular carcinoma: an analysis of 57 patientsB I Carr, I Dvorchik
Journal of Hepato-Biliary-Pancreatic Surgery|July 31, 1998
Liver transplantation in the treatment of hepatocellular carcinomaJ W Marsh, I Dvorchik, S Iwatsuki
Digestive Diseases and Sciences|April 17, 2007
Causes of death in patients with unresectable hepatocellular carcinomaO F M Couto, I Dvorchik, B I Carr
Cancer|January 29, 2000
Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?J W Marsh, I Dvorchik, C A Bonham, et al.
Journal of Viral Hepatitis|January 1, 1997
Liver transplantation for acute liver failure: outcome analysisA O Shakil, I Dvorchik, J J Fung, et al.
Computers in Biology and Medicine|September 1, 1996
Multisolutional clustering and quantization algorithm (MCQ)I Dvorchik, W Marsh, V Gurari, et al.
Methods of Information in Medicine|March 1, 1996
Performance of multi-layer feedforward neural networks to predict liver transplantation outcomeI Dvorchik, M Subotin, W Marsh, et al.
JAMA|July 16, 1997
Should reimbursement be denied for liver transplantation in patients with hepatocellular carcinoma?J W Marsh, I Dvorchik, A Casavilla, et al.
Transplantation|February 12, 1999
Strategies to expand the donor pool for pancreas transplantationS Kapur, C A Bonham, S F Dodson, et al.
Transplantation Proceedings|March 20, 1999
Potential use of marginal donors for pancreas transplantationC A Bonham, S Kapur, S F Dodson, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 15, 2000
Effects of cisplatin dose intensity on response and survival for patients with unresectable and untransplantable hepatocellular carcinoma: an analysis of 57 patientsB I Carr, I Dvorchik
Journal of Hepato-Biliary-Pancreatic Surgery|July 31, 1998
Liver transplantation in the treatment of hepatocellular carcinomaJ W Marsh, I Dvorchik, S Iwatsuki
Digestive Diseases and Sciences|April 17, 2007
Causes of death in patients with unresectable hepatocellular carcinomaO F M Couto, I Dvorchik, B I Carr
Cancer|January 29, 2000
Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?J W Marsh, I Dvorchik, C A Bonham, et al.
Journal of Viral Hepatitis|January 1, 1997
Liver transplantation for acute liver failure: outcome analysisA O Shakil, I Dvorchik, J J Fung, et al.
Computers in Biology and Medicine|September 1, 1996
Multisolutional clustering and quantization algorithm (MCQ)I Dvorchik, W Marsh, V Gurari, et al.
Methods of Information in Medicine|March 1, 1996
Performance of multi-layer feedforward neural networks to predict liver transplantation outcomeI Dvorchik, M Subotin, W Marsh, et al.
JAMA|July 16, 1997
Should reimbursement be denied for liver transplantation in patients with hepatocellular carcinoma?J W Marsh, I Dvorchik, A Casavilla, et al.
Transplantation|February 12, 1999
Strategies to expand the donor pool for pancreas transplantationS Kapur, C A Bonham, S F Dodson, et al.
Transplantation Proceedings|March 20, 1999
Potential use of marginal donors for pancreas transplantationC A Bonham, S Kapur, S F Dodson, et al.
Pageof 5